Rho Chi Post

An award-winning, electronic, student-operated newsletter publication by the St. John's University College of Pharmacy and Health Sciences Rho Chi Beta Delta chapter

Menu

Skip to content
  • Home
  • Issues
    • Current Issue
    • All Issues
  • Articles
    • Featured
    • In the News / Politics
    • Events
    • Clinical
    • Advice / Opinions
    • Puzzles
    • Recently in PubMed
  • For Authors
    • Author Guidelines
    • AMA Citation Generator
    • Sign Up for Article(s)
    • Suggest Article(s)
    • Submit Article(s)
    • Check Statuses
    • Cite Your Article
  • About Us
    • About the Rho Chi Post
    • The Editorial Team
  • Apply for a Position
  • Subscribe
  • Login

Tag Archives: breast

Riociguat (Adempas®) New Drug for Pulmonary Hypertens...
April 1, 2014 - Clinical , Featured

By: Hayeon Na, Co-Copy Editor [Content-Focused] – On October 8th of 2013, Bayer’s new drug riociguat (Adempas®) was approved for the treatment of patients whose pulmonary hypertension (PH) belongs in WHO groups 1 and 4.1 Riociguat (Adempas®) is a soluble guanylate cyclase (sGC) stimulator, and currently the only one of its kind on the market.…

The Surgeon General’s 2014 Report on Smoking...
April 1, 2014 - Featured , In the News / Politics

By: Ada Seldin, Staff Editor – Since the first release of the Surgeon General’s Report on smoking 50 years ago, it has become clear that smoking results in premature death and a myriad of diseases, affecting almost every organ system. Public health initiatives to increase awareness, prevent initiation, and promote smoking cessation have been marginally…

New Hepatitis C Drug Receives FDA Approval...
January 1, 2014 - Clinical , Featured

By: Ada Seldin, Staff Editor – On November 22, 2013, simeprevir (Olysio®), a new agent to treat chronic hepatitis C, received approval under the FDA’s priority review program. Simeprevir is an NS3/4A protease inhibitor that blocks the replication of the hepatitis C virus. Two other drugs from the same class, boceprevir and telaprevir, which were…

Do You Know Your Organizations?: PDC...
January 1, 2014 - Events

Phi Delta Chi (PDC) is a national professional Pharmacy fraternity, which has been on the St. John’s University campus since 1958. Phi Delta Chi works with many other organizations to advance the science of pharmacy and allied interests both on and off campus. The brothers of Phi Delta Chi have hosted and attended many events,…

Possible Mandatory Lung Cancer Screening...
December 1, 2013 - Featured , In the News / Politics

By: Jenny Park, PharmD Candidate c/o 2015 – Lung cancer takes away the lives of about 160,000 individuals annually, which is more than a quarter of all cancer deaths.1 The U.S Preventive Service Task Force is now recommending lung cancer screenings for heavy smokers which could save up to 20,000 lives a year (or about 13%…

Canagliflozin (Invokana®): New Type 2 Diabetes Drug...
October 1, 2013 - Clinical

By: Sang Hyo Kim, Staff Editor – On March 29th 2013, the U.S Food and Drug Administration approved canagliflozin (Invokana®), a new form of a diabetic drug for patients with type 2 diabetes mellitus.1 Canagliflozin is in a new class of medications called sodium glucose co-transporter 2 (SGLT2) inhibitors and is the only oral, once-daily…

Angelina Jolie’s Double Mastectomy: What it Reveals A...
July 1, 2013 - Professional Advice / Opinions

By Sang Hyo Kim, Staff Editor – Angelina Jolie, the actress recognized for her charismatic beauty, revealed to the New York Times that she had undergone double mastectomy, the surgical removal of the breasts. Because her mother died of ovarian cancer at 56, when Jolie learned that she had a mutation in her BRCA1 gene,…

Drug Shortage Update: FDA Successfully Alleviates Chemo...
March 1, 2012 - In the News / Politics

By: Mahdieh Danesh Yazdi – As previously reported, there is currently great concern in the medical community because of the growing number of drug shortages.  Many of these are drugs that are critical to patient care, such as chemotherapy agents and antibiotics.  Last October, President Obama issued an executive order in an attempt to curb…

Proton Pump Inhibitors and the Treatment of Osteoporosi...
February 1, 2012 - Clinical , Featured

By: Neal Shah – Osteoporosis is a disease of the bone characterized by decreased bone mineral density (BMD), which reduces the ability of bone to provide adequate structural support.  The main cause of this decreased BMD is inadequate calcium intake or absorption.  The decreased BMD can cause diffuse lesions throughout the skeletal system and can…

It’s Time to Get Involved!...
November 1, 2011 - Professional Advice / Opinions

By: Khilna Patel, PharmD Candidate c/o 2012 – Top academic achievement is a plus but is not the only thing to strive for – college is about developing one‘s self as a whole. There are many opportunities to get involved. Don‘t be afraid to try everything that may interest you because it will only bring…

Student Pharmacist Star of the Month: Jaclyn Scott...
November 1, 2011 - Professional Advice / Opinions

By: Marie Huang – Every month, Rho Chi Post has the wonderful opportunity to sit down with an inspiring leader among the student pharmacists here at St. John‘s – someone who is not afraid to stand apart from the crowd and can be the change he or she wants to see in the world. This…

The Industry: Generics Drugs and Intellectual Property ...
October 1, 2011 - Featured , Professional Advice / Opinions

By: Ebey P. Soman – The World Trade Organization (WTO) and its member nations met in Uruguay in 1994 to establish international norms for trade, economy, and development. They developed the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS), which provided patent protection for pharmaceutical companies to make brand name medications and market those…



Do You Want to be a Published Author? Submit your Article(s) Today!



Tweets by @RhoChiPost

HOME: Home Page

VOLUMES / ISSUES: 14 . 13 . 12 . 11 . 10 . 9 . 8 . 7 . 6 . 5 . 4 . 3 . 2 . 1

ARTICLES: Featured . In the News / Politics . Events . Clinical . Advice / Opinions . Puzzles

FOR AUTHORS: Guidelines . AMA Citation Generator . Sign Up . Suggest . Submit . Cite

ABOUT US: About the Rho Chi Post . The Editorial Team . Apply for a Position

SUBSCRIBE: Google Groups Email List


Copyright © 2011-2025 Rho Chi Post